Signaling‐sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor

The thyrotropin receptor [thyroidstimulating hormone receptor (TSHR)], a G‐proteincoupled receptor (GPCR), is endogenously activated by thyrotropin, which binds to the extracellular region of the receptor. We previously identified a low‐molecular‐weight (LMW) agonist of the TSHR and predicted its allosteric binding pocket within the receptor's transmembrane domain. Because binding of the LMW agonist probably disrupts interactions or leads to formation of new interactions among amino acid residues surrounding the pocket, we tested whether mutation of residues at these positions would lead to constitutive signaling activity. Guided by molecular modeling, we performed site‐directed mutagenesis of 24 amino acids in this spatial region, followed by functional characterization of the mutant receptors in terms of expression and signaling, measured as cAMP accumulation. We found that mutations V421I, Y466A, T501A, L587V, M637C, M637W, S641A, Y643F, L645V, and Y667A located in several helices exhibit constitutive activity. Of note is mutation M637W at position 6.48 in transmembrane helix 6, which has a significant effect on the interaction of the receptor with the LMW agonist. In summary, we found that a high proportion of residues in several helices surrounding the allosteric binding site of LMW ligands in the TSHR when mutated lead to constitutively active receptors. Our findings of signaling‐sensitive residues in this region of the transmembrane bundle may be of general importance as this domain appears to be evolutionarily retained among GPCRs.—Kleinau, G., Haas, A.‐K., Neumann, S., Worth, C. L., Hoyer, I., Furkert, J., Rutz, Gershengorn, M. C, Schülein, R., Krause, G. Signalingsensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor. FASEBJ. 24, 2347–2354 (2010). www.fasebj.org

[1]  J. Ramachandran,et al.  Structure and Function of G Protein Coupled Receptors , 1990, Pharmaceutical Research.

[2]  T. Mori,et al.  TSH receptor and LH receptor, 1995. , 1995, Endocrine journal.

[3]  L. Pardo,et al.  A molecular dissection of the glycoprotein hormone receptors. , 2004, Trends in biochemical sciences.

[4]  R. Paschke,et al.  Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  Toru Mori,et al.  TSH receptor and LH receptor, 1996. , 1996, Endocrine journal.

[6]  Didier Rognan,et al.  A chemogenomic analysis of the transmembrane binding cavity of human G‐protein‐coupled receptors , 2005, Proteins.

[7]  M. Gershengorn,et al.  Two Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation* , 2009, Journal of Biological Chemistry.

[8]  B. Weintraub,et al.  Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. , 2002, Physiological reviews.

[9]  P. Corvol,et al.  Lessons from constitutively active mutants of G protein-coupled receptors , 2002, Trends in Endocrinology & Metabolism.

[10]  B. Raaka,et al.  Understanding the structural and functional differences between mouse thyrotropin‐releasing hormone receptors 1 and 2 , 2008, Proteins.

[11]  E. Nieschlag,et al.  The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. , 1997, Endocrine reviews.

[12]  R. Paschke,et al.  Molecular and structural effects of inverse agonistic mutations on signaling of the thyrotropin receptor – a basally active GPCR , 2008, Cellular and Molecular Life Sciences.

[13]  B. Raaka,et al.  A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. , 2008, Endocrinology.

[14]  G. Krause,et al.  Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. , 2009, Endocrine reviews.

[15]  D S Moss,et al.  Main-chain bond lengths and bond angles in protein structures. , 1993, Journal of molecular biology.

[16]  Xavier Deupi,et al.  Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.

[17]  R. Seifert,et al.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  B. Raaka,et al.  Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice , 2009, Proceedings of the National Academy of Sciences.

[19]  R. Paschke,et al.  Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor* , 2007, Journal of Biological Chemistry.

[20]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[21]  Gerd Krause,et al.  Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns. , 2006, Journal of medicinal chemistry.

[22]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[23]  Katrin Sangkuhl,et al.  Mutant G-protein-coupled receptors as a cause of human diseases. , 2004, Pharmacology & therapeutics.

[24]  R. Paschke,et al.  Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. , 2006, European journal of endocrinology.

[25]  T. Schwartz,et al.  Common Structural Basis for Constitutive Activity of the Ghrelin Receptor Family* , 2004, Journal of Biological Chemistry.

[26]  A. IJzerman,et al.  G protein‐coupled receptors of the hypothalamic–pituitary–gonadal axis: A case for gnrh, LH, FSH, and GPR54 receptor ligands , 2008, Medicinal research reviews.

[27]  I. Huhtaniemi,et al.  Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. , 2000, Endocrine reviews.

[28]  R. Paschke,et al.  A Low Molecular Weight Agonist Signals by Binding to the Transmembrane Domain of Thyroid-stimulating Hormone Receptor (TSHR) and Luteinizing Hormone/Chorionic Gonadotropin Receptor (LHCGR)* , 2006, Journal of Biological Chemistry.

[29]  M. Ascoli,et al.  The lutropin/choriogonadotropin receptor, a 2002 perspective. , 2002, Endocrine reviews.

[30]  S. Costagliola,et al.  Activating mutations of TSH receptor. , 2004, Annales d'endocrinologie.

[31]  J. Konopka,et al.  Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Schwartz,et al.  Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.

[33]  K. Palczewski,et al.  Comparative Analysis of GPCR Crystal Structures † , 2009, Photochemistry and photobiology.

[34]  B. Kobilka,et al.  New G-protein-coupled receptor crystal structures: insights and limitations. , 2008, Trends in pharmacological sciences.

[35]  Raymond C Stevens,et al.  Discovery of new GPCR biology: one receptor structure at a time. , 2009, Structure.

[36]  U. Leser,et al.  Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. , 2007, Molecular endocrinology.

[37]  B. Smith,et al.  Assays of cyclic nucleotides , 1993, Applied biochemistry and biotechnology.